Clinical Trial Update: Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure [Phase 2]

View source ↗

Summary

This completed Phase 2 trial assesses a novel subcutaneous preparation of furosemide to facilitate early supported discharge for patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Furosemide (subcutaneous preparation) (furosemide)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Heart Failure | Phase 2 | Status: COMPLETED